Toxicology of organophosphate and carbamate compounds /
Saved in:
Corporate Authors: | |
---|---|
Group Author: | |
Published: |
Elsevier Academic Press,
|
Publisher Address: | Amsterdam : |
Publication Dates: | 2006. |
Literature type: | eBook |
Language: | English |
Subjects: | |
Online Access: |
http://www.sciencedirect.com/science/book/9780120885237 |
Carrier Form: | 1 online resource (xvi, 763 pages) : illustrations |
Bibliography: | Includes bibliographical references and index. |
ISBN: |
9780080543109 0080543103 9780120885237 0120885239 |
Index Number: | RA1270 |
CLC: | S482.3 |
Contents: | Cover -- Toxicology of Organophosphate and Carbamate Compounds -- Copyright Page -- Contents -- Contributors -- Foreword -- Section I: Uses, Abuses, & Epidemiology -- Chapter 1. Introduction -- Chapter 2. Classification and Uses of Organophosphates and Carbamates -- Chapter 3. Therapeutic Uses of Cholinesterase Inhibitors in Neurodegenerative Diseases -- Chapter 4. Coadministration of Memantine with Acetylcholinesterase Inhibitors: Preclinical and Clinical Evidence -- Chapter 5. Cholinesterase Inhibitors as Chemical Warfare Agents: Community Preparedness Guidelines -- Chapter 6. Organophosphates and the Gulf War Syndrome -- Chapter 7. The Bhopal Accident and Methyl Isocyanate Toxicity -- Chapter 8. Global Epidemiology of Organophosphate and Carbamate Poisonings -- Section II: Pharmacokinetics & Metabolism -- Chapter 9. Physiologically Based Pharmacokinetic Modeling of Organophosphorus and Carbamate Pesticides -- Chapter 10. Metabolism of Organophosphorus and Carbamate Pesticides -- Chapter 11. Interspecies Variation in Toxicity of Cholinesterase Inhibitors -- Section III: Esterases, Receptors, Mechanisms, & Tolerance Development -- Chapter 12. Structure and Function of Cholinesterases -- Chapter 13. Cholinesterase Pharmacogenetics -- Chapter 14. Methods for Measuring Cholinesterase Activities in Human Blood -- Chapter 15. Interactions of Organophosphorus and Carbamate Compounds with Cholinesterases -- Chapter 16. Structure, Function, and Regulation of Carboxylesterases -- Chapter 17. Noncholinesterase Mechanisms of Central and Peripheral Neurotoxicity: Muscarinic Receptors and Other Targets -- Chapter 18. Paraoxonase Polymorphisms and Toxicity of Organophosphates -- Chapter 19. Tolerance Development to Toxicity of Cholinesterase Inhibitors -- Section IV: Organ Toxicity -- Chapter 20. Central Nervous System Effects and Neurotoxicity -- Chapter 21. Developmental Neurotoxicity of Organophosphates: A Case Study of Chlorpyrifos -- Chapter 22. In Vitro Models for Testing Organophosphate-lnduced Neurotoxicity and Remediation -- Chapter 23. Electrophysiological Mechanisms in Neurotoxicity of Organophosphates and Carbamates -- Chapter 24. Behavioral Toxicity of Cholinesterase Inhibitors -- Chapter 25. Peripheral Nervous System Effects and Delayed Neuropathy -- Chapter 26. Intermediate Syndrome in Organophosphate Poisoning -- Chapter 27. Cardiovascular Toxicity of Cholinesterase lnhibitors -- Chapter 28. Pulmonary Toxicity of Cholinesterase Inhibitors -- Chapter 29. Approaches to Defining and Evaluating the Inhalation Pharmacology and Toxicology Hazards of Anticholinesterases -- Chapter 30. Dermal Absorption/Toxicity of Organophosphates and Carbamates -- Chapter 31. Local and Systemic Ophthalmic Pharmacology and Toxicology of Organophosphate and Carbamate Anticholinesterases -- Chapter 32. Reproductive Toxicity of Organophosphate and Carbamate Pesticides -- Chapter 33. Placental Toxicity of Organophosphate and Carbamate Pesticides -- Chapter 34. Endocrine Disruption by Organophosphate and Carbamate Pesticides -- Chapter 35. Organophosphates, Carbamates, and the Immune System -- Section V: Nonspecific To. |